Risk of malignancy in patients with inflammatory bowel disease: A population-based cohort study from China.
Zhang H, Zhang M, Chen X, Guo M, Zhou R, Lv H, Li Y, Tan B, Li J, Xu H, Zheng W, Yang H, Qian J.
Zhang H, et al. Among authors: li y, li j.
Int J Cancer. 2022 Jun 1;150(11):1770-1778. doi: 10.1002/ijc.33932. Epub 2022 Feb 10.
Int J Cancer. 2022.
PMID: 35037241
Free article.